Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Corinne
Corinne Adamonis, Fairview Park, OH US
| Patent application number | Description | Published |
|---|---|---|
| 20080274664 | Narrow Body Model Glider - There is provided a model glider having a wing having a first thickness and a body having a second thickness. The wing is operatively connected to the body. The ratio of the first thickness of the wing to the second thickness of the body is about 2 to 3. | 11-06-2008 |
Corinne Appolonia-Nouzille, Lausanne CH
| Patent application number | Description | Published |
|---|---|---|
| 20080311211 | Easily Dispersible Lipidic Phase - The present invention relates to the use of a lipidic phase comprising an oil and a lipophilic additive (LPA), which is suitable to make an oil-in-water emulsion by application of low energy or a manual operation. The lipidic phase contains a Lipophilic Additive (LPA) which forms self-assembly structures inside the emulsion oil droplets. The aqueous phase contains a hydrophilic emulsifier and the lipidic and aqueous phases are mixed without using classical high shearing devices or homogenisers. | 12-18-2008 |
Corinne Auge-Gouillou, Veretz FR
| Patent application number | Description | Published |
|---|---|---|
| 20090311743 | Process for the Production, in Prokaryotes, of Active, Stable Transposases of Mariner Mobile Genetic Elements - The present invention relates to a process for the production, by a prokaryotic host cell, of an active, stable transposase of a Mariner mobile genetic element belonging to the | 12-17-2009 |
| 20110124703 | MOLECULES COMPRISING A BIS(HETEROARYL)MALEIMIDE BACKBONE, AND USE THEREOF IN THE INHIBITION OF DDE/DDD ENZYMES - The invention concerns molecules with a bis-(heteroaryl)maleimide structure and having inhibiting characteristics with respect to enzymes with a catalytic pocket comprising the invariant amino acids D, D and E or D, D and D, such as transposases, RAG recombinases or retroviral integrases. The invention also concerns the use of said molecules for in vitro, ex vivo or in vivo inhibition of transposases, RAG recombinases and retroviral integrases such as HIV integrase, as well as the use of said molecules in the treatment of diseases associated with these enzymes in an animal or human host, in particular in the treatment of AIDS. | 05-26-2011 |
Corinne Benquet, Laval CA
| Patent application number | Description | Published |
|---|---|---|
| 20090069549 | Protein Extraction buffer, a kit comprising it and method of its use - Disclosed are detergent-free protein extract buffers to extract proteins from formalin-fixed paraffin-embedded tissue sections, kit comprising the buffer, and methods for using the buffer to extract proteins from formalin-fixed, paraffin-embedded tissue sections. | 03-12-2009 |
Corinne Bos-Plachez, Baisieux FR
| Patent application number | Description | Published |
|---|---|---|
| 20110202344 | METHOD AND APPARATUS FOR PROVIDING SPEECH OUTPUT FOR SPEECH-ENABLED APPLICATIONS - Techniques for providing speech output for speech-enabled applications. A synthesis system receives from a speech-enabled application a text input including a text transcription of a desired speech output. The synthesis system selects one or more audio recordings corresponding to one or more portions of the text input. In one aspect, the synthesis system selects from audio recordings provided by a developer of the speech-enabled application. In another aspect, the synthesis system selects an audio recording of a speaker speaking a plurality of words. The synthesis system forms a speech output including the one or more selected audio recordings and provides the speech output for the speech-enabled application. | 08-18-2011 |
Corinne Breque, Vanves FR
| Patent application number | Description | Published |
|---|---|---|
| 20080206190 | Glycosylated IL-7, Preparation And Uses - The present invention relates to new and improved interleukin-7 polypeptides, as well as compositions comprising the same, their preparation and uses. The invention more particularly relates to hyperglycosylated IL-7 polypeptides having improved properties, as well as their manufacture and therapeutic uses. The invention also discloses novel IL-7 polypeptides having modified amino acid sequences containing artificially created glycosylation site(s), as well as corresponding nucleic acid molecules, vectors and recombinant host cells. The invention also relates to the use of such polypeptides, cells or nucleic acids for curative or preventive treatment of mammalian subjects, including human subjects. | 08-28-2008 |
| 20100196312 | GLYCOSYLATED IL-7, PREPARATION AND USES - The present invention relates to new and improved interleukin-7 polypeptides, as well as compositions comprising the same, their preparation and uses. The invention more particularly relates to hyperglycosylated IL-7 polypeptides having improved properties, as well as their manufacture and therapeutic uses. The invention also discloses novel IL-7 polypeptides having modified amino acid sequences containing artificially created glycosylation site(s), as well as corresponding nucleic acid molecules, vectors and recombinant host cells. The invention also relates to the use of such polypeptides, cells or nucleic acids for curative or preventive treatment of mammalian subjects, including human subjects. | 08-05-2010 |
| 20120016104 | GLYCOSYLATED IL-7, PREPARATION AND USES - The present invention relates to new and improved interleukin-7 polypeptides, as well as compositions comprising the same, their preparation and uses. The invention more particularly relates to hyperglycosylated IL-7 polypeptides having improved properties, as well as their manufacture and therapeutic uses. The invention also discloses novel IL-7 polypeptides having modified amino acid sequences containing artificially created glycosylation site(s), as well as corresponding nucleic acid molecules, vectors and recombinant host cells. The invention also relates to the use of such polypeptides, cells or nucleic acids for curative or preventive treatment of mammalian subjects, including human subjects. | 01-19-2012 |
Corinne Bushelman, Cumming, GA US
| Patent application number | Description | Published |
|---|---|---|
| 20100314793 | METHOD FOR MAKING A POLYAMIDE HOLLOW BODY - Method for making a hollow body comprising, as sole layer(s), at least one layer L1 consisting of a polyamide composition comprising an aromatic polyamide and an impact modifier, said method comprising extruding the polyamide composition through a die. | 12-16-2010 |
| 20110028650 | METHOD FOR MAKING A POLYAMIDE FILM - Method for making a film comprising, as sole layer(s), at least one layer L1 consisting of a polyamide composition comprising an aromatic polyamide and an impact modifier, said method comprising extruding the polyamide composition into the film. | 02-03-2011 |
Corinne Bushelman, Us- Cumming, GA US
| Patent application number | Description | Published |
|---|---|---|
| 20080241562 | Impact-Modified Polyamide Film - Films made from impact-modified polyamide. | 10-02-2008 |
Corinne Cabassud, Saint-Orens De Gameville FR
| Patent application number | Description | Published |
|---|---|---|
| 20120018313 | NOVEL BIOTRACERS AND USES THEREOF FOR CONTROLLING FILTRATION PLANTS - The present invention relates to novel biotracers, to a method for preparing same, and to a method for detecting the biotracers and for monitoring filtration systems. | 01-26-2012 |
Corinne Cayatte, San Francisco, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110212104 | INFLAMMATORY BOWEL DISEASE BIOMARKERS AND RELATED METHODS OF TREATMENT - Biomarkers associated with inflammatory bowel disease (IBD) are provided, as well as methods of using such biomarkers for diagnosing, assessing and monitoring disease progression. The biomarkers may be measured at the protein level or the gene expression level Biomarkers may be tracked individually or in groups of two or more. The disclosed biomarkers may find particular utility in monitoring a course of therapy, such as treatment with an IL-23 antagonist. Changes in biomarker levels can also be used to confirm target engagement and therapeutic efficacy. Changes in biomarkers can also be used inform modification of a therapeutic regimen, for example to increase or decrease dosing of a therapeutic agent, such as an anti-IL-23 or anti-IL-23R anti-body. | 09-01-2011 |
Corinne Chaimbault, Marseille FR
| Patent application number | Description | Published |
|---|---|---|
| 20090203747 | NOVEL CHEMICAL COMPOUNDS AND THE USES THEREOF AS A MEDICINE - The present invention relates to the field of pharmacy, especially the treatment of neurodegenerative diseases. The invention specifically relates to a family of chemical compounds for which a neuroprotective activity has been demonstrated. | 08-13-2009 |
| 20110224180 | NOVEL CHOLEST-4-EN-3-ONE OXIME DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND PREPARATION METHOD - The present invention relates to novel chemical compounds, in particular cholest-4-en-3-one oxime derivatives and to the use thereof as medicaments, especially as cytoprotective medicaments, in particular neuroprotective, cardioprotective and/or hepatoprotective medicaments. | 09-15-2011 |
| 20110275680 | NOXEL OXIME DERIVATIVES OF 3, 5-SECO-4-NOR-CHOLESTANE, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHOD FOR PREPARING SAME - The invention relates to novel chemical compounds, in particular oxime derivatives of 3,5-seco-4-nor-cholestane, to the application thereof as drugs, in particular cytoprotective drugs, and more particularly as neuroprotective, cardioprotective and/or hepatoprotective drugs. | 11-10-2011 |
Corinne Chovet, Conflans Ste Honorine FR
| Patent application number | Description | Published |
|---|---|---|
| 20110226746 | Process for Laser-ARC Hybrid Welding Aluminized Metal Workpieces - Process for laser welding at least one metal workpiece ( | 09-22-2011 |
Corinne Daumer, Strombeek BE
| Patent application number | Description | Published |
|---|---|---|
| 20080242569 | LIQUID DETERGENT COMPOSITION SYSTEM HAVING A VISUAL INDICATION CHANGE - A detergent composition with a pH of 7.5 to 13 having a pH dye and a sulfate or sulphonate surfactant that changes color when added to a volume of water such that a blue or green color results from the dilution of the detergent composition. | 10-02-2008 |
| 20080242570 | LIQUID COMPOSITION SYSTEM HAVING A VISUAL INDICATION CHANGE - A detergent composition having a pH dye and an amphoteric surfactant that changes color when added to a volume of water. | 10-02-2008 |
Corinne Dive-Reclus, Hertfordshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20080250082 | Method of Backing Up and Restoring Data in a Computing Device - Installable files installed on a first computing device are backed up to a second computing device and restored from the second device to the first device and/or a further device using the same means to verify the integrity of the files as used for the original installation of the files on the first device. | 10-09-2008 |
| 20100306517 | SECURITY OF OPERATION OF A COMPUTING DEVICE THROUGH THE USE OF VENDOR IDS - An installer for a computing device determines firstly whether or not a software package for installation has been signed. If the package is signed it is installed on the device. However, if the package is unsigned, the installer will only install the package on the device if it contains a non-null VID (vendor identity). | 12-02-2010 |
Corinne Dive-Reclus, St Albans GB
| Patent application number | Description | Published |
|---|---|---|
| 20120072917 | METHOD AND APPARATUS FOR DISTRIBUTING COMPUTATION CLOSURES - An approach is provided for backend based computation closure oriented distributed computing. A computational processing support infrastructure receives a request for specifying one or more processes executing on a device for distribution over a computation space. The computational processing support infrastructure also causes, at least in part, serialization of the one or more processes as one or more closure primitives, the one or more closure primitives representing computation closures of the one or more processes. The computational processing support infrastructure further causes, at least in part, distribution of the one or more closure primitives over the computation space based, at least in part, on a cost function. | 03-22-2012 |
Corinne Duffy (varon), Meyzieu FR
| Patent application number | Description | Published |
|---|---|---|
| 20110117282 | PROCESS OF OBTAINING A POLYURETHANE COATING COMPOSITION HAVING EXTENDED POT-LIFE - The invention relates to polyurethane coating compositions having a pot-life of at least 8 hours and a de-blocking temperature of 50-100° C. The composition comprises: a) a blocked isocyanate formed by mixing at least one isocyanate functional compound with at least one imidazole and b) at least one polyol. The composition can be used on heat sensitive substrates. Methods of making such a composition are also described. The invention was applications in the coating industry. | 05-19-2011 |
Corinne Eenschooten, Vanlose FR
| Patent application number | Description | Published |
|---|---|---|
| 20090252810 | Aryl/alkyl Succinic Anhydride-Hyaluronan Derivatives - The present invention relates to the modification of hyaluronic acid (HA) with aryl/alkyl succinic anhydrides (ASA) to produce aryl/alkyl succinic anhydride HA derivatives, to the derivatives as such, and to their applications and uses, particularly in the cosmetic and biomedical industries. The ASA-HA derivatives are expected to have interesting properties that can be used for advanced formulation (bind stronger to the skin compared to non-modified HA), possibly also in delivery systems for actives or drugs by encapsulation (nano/micro capsules) or formation of nano/micro spheres. Further, the low MW ASA-HA derivatives are expected to penetrate the skin more efficiently than non-modified HA of the same MW. | 10-08-2009 |
Corinne Eenschooten, Vanlose DK
| Patent application number | Description | Published |
|---|---|---|
| 20110257123 | ARYL/ALKYL VINYL SULFONE HYALURONIC ACID DERIVATIVES - A hyaluronic acid derivative, and methods of producing and using said derivative, the derivative comprising n repeating units and having the general structural formula (I), wherein, in at least one repeating unit, one or more of R1, R2, R3, R4 comprises an etherbound aryl/alkyl sulfone having the general structural fomula (II), wherein R comprises an alkyl- or aryl-group, and otherwise R1, R2, R3, R4 are hydroxyl groups, OH. | 10-20-2011 |
| 20110319357 | Hyaluronic Acid Derivatives - The present invention relates to the modification of hyaluronic acid (HA) with aryl/alkyl succinic anhydrides (ASA) to produce aryl/alkyl succinic anhydride HA derivatives, to the derivatives as such, and to their applications and uses, particularly in the cosmetic and biomedical industries. The ASA-HA derivatives are expected to have interesting properties that can be used for advanced formulation (bind stronger to the skin compared to non-modified HA), possibly also in delivery systems for actives or drugs by encapsulation (nano/micro capsules) or formation of nano/micro spheres. Further, the low MW ASA-HA derivatives are expected to penetrate the skin more efficiently than non-modified HA of the same MW. | 12-29-2011 |
Corinne Fillol, Mouroux FR
| Patent application number | Description | Published |
|---|---|---|
| 20090304195 | METHOD AND DEVICE FOR DIAGNOSING THE OPERATING STATE OF A SOUND SYSTEM - The invention relates to a method of diagnosing the operating state, in situ, of a sound system comprising at least one loudspeaker suitable for being connected to an audio player and arranged in an at least partially closed space, characterized in that it comprises the following steps: | 12-10-2009 |
Corinne Fonquerne, Villeurbanne FR
| Patent application number | Description | Published |
|---|---|---|
| 20090301354 | Method For Compacting A Hydraulic Binder And Novel Milled Pellets - A method of compressing a composition includes compacting a hydraulic binder in a quantity greater than 95% by weight and a disintegrating agent in a quantity less than or equal to 0.5% by weight, into compacts in a roller press. The milled pellet of a composition including a hydraulic binder in a quantity greater than 95% by weight and a disintegrating agent in a quantity less than or equal to 0.5% by weight. | 12-10-2009 |
Corinne Gavory, Montbazin FR
| Patent application number | Description | Published |
|---|---|---|
| 20100190827 | POLYMORPHIC FORM OF RIMONABANT, METHOD FOR PREPARING IT AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT - The present invention relates to a novel crystalline polymorph of rimonabant, its method of preparation and the pharmaceutical compositions containing this novel polymorph. | 07-29-2010 |
Corinne Gorskey, Woodridge, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20100096398 | POUR AND SEAL ASSEMBLY AND METHOD OF USING THE SAME - The invention is directed to a pour and seal assembly and method of using the same. The assembly includes a closure configured to seal an opening of a food stuffs container including a lid configured to securely cover an opening to a container holding food stuffs, a lid collar configured to, in part, form the opening and further configured to engage the lid and seal the opening to the container, and an internal collar configured to be arranged at least partially in the lid collar and to hold a portion of the container against the lid collar and further, in part, seal the opening to the container. | 04-22-2010 |
Corinne Groiselle, Crosne FR
| Patent application number | Description | Published |
|---|---|---|
| 20100288932 | METHOD OF ANALYSIS OF AN OBJECT BY NEUTRON INTERROGATION, BY THE ASSOCIATED PARTICLE TECHNIQUE, AND DEVICE FOR IMPLEMENTING THE METHOD | 11-18-2010 |
Corinne Hanotin, La Celle Saint Cloud FR
| Patent application number | Description | Published |
|---|---|---|
| 20090197917 | USE OF RIMONABANT FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION AND TREATMENT OF TYPE 2 DIABETES - The invention relates to the use of rimonabant, either alone or combined with another active ingredient, for the preparation of medicaments useful in the prevention and treatment of type 2 diabetes or non-insulin-dependent diabetes and/or its complications. | 08-06-2009 |
Corinne Ianigro, Grenoble FR
| Patent application number | Description | Published |
|---|---|---|
| 20080309594 | CONTROL OF AN ELECTROLUMINESCENT DISPLAY - A device for controlling an electroluminescent matrix display by successive selection of its lines, including a column control circuit having circuitry capable of placing, at the beginning of the selection of a line, the display column at a precharge voltage based on the operating voltage of the previous line, the column control circuit also having circuitry capable of modifying the precharge voltage according to the difference between luminance instructions of the previous line and those of the selected line. | 12-18-2008 |
Corinne Lac, Beynost FR
| Patent application number | Description | Published |
|---|---|---|
| 20080316747 | Luminaire with Louver Members - The invention relates to a reflector for a luminaire. The reflector comprises a cavity ( | 12-25-2008 |
Corinne Ladous, Salem, NH US
| Patent application number | Description | Published |
|---|---|---|
| 20110117726 | BONDED INTERMEDIATE SUBSTRATE AND METHOD OF MAKING SAME - A method includes growing a first epitaxial layer of III-nitride material, forming a damaged region by implanting ions into an exposed surface of the first epitaxial layer, and growing a second epitaxial layer of III-nitride material on the exposed surface of the first epitaxial layer. A level of defects present in the second epitaxial layer is less than a level of defects present in the first epitaxial layer. | 05-19-2011 |
Corinne Ladous, Pasadena, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090278233 | BONDED INTERMEDIATE SUBSTRATE AND METHOD OF MAKING SAME - A method includes growing a first epitaxial layer of III-nitride material, forming a damaged region by implanting ions into an exposed surface of the first epitaxial layer, and growing a second epitaxial layer of III-nitride material on the exposed surface of the first epitaxial layer. A level of defects present in the second epitaxial layer is less than a level of defects present in the first epitaxial layer. | 11-12-2009 |
Corinne Le Buhan, Les Paccots CH
| Patent application number | Description | Published |
|---|---|---|
| 20080219643 | METHOD TO CONTROL THE ACCESS TO CONDITIONAL ACCESS AUDIO/VIDEO CONTENT - The present invention aims at solving the financial revenue loss due to the presence of digital video recorders that allow skipping the commercial breaks. | 09-11-2008 |
| 20100077390 | METHOD FOR UPDATING AND MANAGING AN AUDIOVISUAL DATA PROCESSING APPLICATION INCLUDED IN A MULTIMEDIA UNIT BY MEANS OF A CONDITIONAL ACCESS MODULE - A method to force a multimedia unit to update an application for viewing broadcast conditional access content by linking said update to an update of the conditional access module firmware. The firmware update is initialized by means of version information transmitted in the content stream. In particular, this version information may be included in ECM or EMM messages or in services information tables in order to be processed by the conditional access module independently from the multimedia unit. The version information comprises of a minimum version and of an available maximum version. If the conditional access module detects that the current version of the firmware is inferior to the available maximum version, it transmits a message requesting an update of the application that initiates downloading a firmware updating from a management center. The update installation is carried out simultaneously in the conditional access module and in the multimedia unit. | 03-25-2010 |
Corinne Leroi, Verona IT
| Patent application number | Description | Published |
|---|---|---|
| 20080262234 | Process for Preparing N, N-Substituted Carbamoyl Halides - The present invention relates to a new and useful process for preparing N,N-substituted carbamoyl halides from secondary amines, carbon dioxide, trialkylsilyl chloride and a halogenating agent. | 10-23-2008 |
Corinne Magliola, Pully CH
| Patent application number | Description | Published |
|---|---|---|
| 20110118204 | NUTRITIONAL COMPOSITION WITH FREE AMINO ACIDS AND STRUCTURED LIPIDS - A nutritional composition is proposed, such as an infant formula composition or an enteral composition for children 3-17 years, that is especially targeted as patients having food allergies or impairments of intestinal absorption. The composition comprises structured lipids. The composition is based on free amino acids and contains a very low amount of peptides or proteins, if any. The composition comprises a source of carbohydrate and has a particular caloric density. The composition can comprise arachidonic acid (ARA) and/or docosahexaenoic acid (DHA). The composition delivers specific nutritional benefits to the patients. | 05-19-2011 |
| 20110195144 | AGE-TAILORED NUTRITION SYSTEM FOR INFANTS - The invention relates to the use of a protein source comprising whey and casein proteins for providing an age-tailored nutrition system to an infant which system comprises two infant formulas each appropriate to an infant of a different age and each comprising the protein source wherein the whey:casein ratio of each formula is chosen in the range from 100:0 to 40:60 and decreases according to the age of the infant and the protein content of each formula is chosen in the range from 1.5 to 3.0 g protein/100 kcal and decreases according to the age of the infant. | 08-11-2011 |
Corinne Mallol, Eslov SE
| Patent application number | Description | Published |
|---|---|---|
| 20080229653 | METHOD AND APPARATUS FOR PRODUCTION OF BIO-ETHANOL AND OTHER FERMENTATION PRODUCTS - The present invention relates to a method and apparatus for converting organic material into a burnable substance, typically a hydrocarbon fuel, such as ethanol. | 09-25-2008 |
| 20100015677 | METHOD AND APPARATUS FOR PRODUCTION OF BIO-ETHANOL AND OTHER FERMENTATION PRODUCTS - A method for converting organic material into hydrocarbon fuel, such as ethanol, the method comprising a fermentation process fermenting the organic material thereby providing a fermentation broth, a separation process separating the fermented material into a hydrocarbon fuel and a residual product, a conversion process at least partly converting the residual product into energy, and a energy distribution process distributing at least some of the energy provided by the conversion process to the fermentation process. | 01-21-2010 |
Corinne Mentell, Louisville, KY US
| Patent application number | Description | Published |
|---|---|---|
| 20080319670 | FEATURE TARGET SELECTION FOR COUNTERMEASURE PERFORMANCE WITHIN A VEHICLE - A target selection system ( | 12-25-2008 |
Corinne Miral, Treillieres FR
| Patent application number | Description | Published |
|---|---|---|
| 20120058139 | NOVEL MULTIMODULAR ASSEMBLY USEFUL FOR INTRACELLULAR DELIVERY - A stabilized multimodular assembly for intracellular delivery comprising a complex of at least one cationic transfection agent and of at least one negatively charged macromolecule, wherein the complex has a theoretical charge ratio ranging from about 0 to about 4, and an efficient amount of at least one amphiphilic block co-polymer acting as a steric colloidal stabilizer with respect to the complex, the block co-polymer having hydrophilic and hydrophobic blocks wherein at least one hydrophilic block is conjugated with at least one targeting ligand. | 03-08-2012 |
Corinne Nadiv, Haifa IL
| Patent application number | Description | Published |
|---|---|---|
| 20090162447 | Spherically Shaped Substances - A particle having a rounded shape and characterized by a substantially smooth surface is disclosed. The particle can be made of a food substance (e.g., nutritional substance or nutraceutical substance), a pharmaceutical (pharmaceutically active ingredient or pharmaceutically acceptable carrier) or a cosmetic substance. | 06-25-2009 |
Corinne Naturel, Rennes FR
| Patent application number | Description | Published |
|---|---|---|
| 20090208131 | Method and Device for Watermarking on Stream - The invention relates in particular to a stream-wise method of watermarking independent of the compression parameters used (for example type of the transform) so as to allow the reading of the watermarking inserted independently of the format of the data received. The watermarking method according to the invention consists in generating a contribution matrix in the transformation space, in projecting it into another domain and in watermarking the data in this domain on the basis of the projected matrix so as to allow a watermark reader operating in the transformed transformation space to read back the inserted watermarking in the transformation space. The contribution matrix representing the modifications induced on the coefficients in the transformation space by insertion of the watermarking cue in this same domain. | 08-20-2009 |
| 20100166251 | Method for Watermarking a Digital Data Set and Device Implementing Said Method - The invention relates to a method of watermarking a data set comprising the steps of: | 07-01-2010 |
Corinne Nouvellon, Mons BE
| Patent application number | Description | Published |
|---|---|---|
| 20100209728 | MAGNETRON CO-SPUTTERING DEVICE - The present invention provides a magnetron co-sputtering device ( | 08-19-2010 |
Corinne Obled, Nozay FR
| Patent application number | Description | Published |
|---|---|---|
| 20110107429 | SYSTEM AND METHOD FOR MANAGING ACCESSIBILITY TO REAL OR VIRTUAL OBJECTS IN DIFFERENT LOCATIONS - A system (S), dedicated to managing accessibility to objects in different locations (L | 05-05-2011 |
Corinne Petit-Frere, Munchen DE
| Patent application number | Description | Published |
|---|---|---|
| 20090081207 | High affinity human and humanized anti-alpha5beta1 integrin function blocking antibodies with reduced immunogenicity - The present invention relates to recombinant human or humanized polypeptides which bind to α5β1 integrin with high affinity and blocking function. Further, diagnostic and pharmaceutic applications of the potypeptides are disclosed. | 03-26-2009 |
Corinne Petit-Frère, Munich DE
| Patent application number | Description | Published |
|---|---|---|
| 20110110944 | ANTI-ALK1 ANTIBODIES AND USES THEREOF - The present invention provides recombinant antigen-binding regions and antibodies and functional fragments containing such antigen-binding regions that are specific for AIk1, which plays an integral role in various disorders or conditions, such as cancer and macular degeneration. These antibodies, accordingly, can be used to treat these and other disorders and conditions. Antibodies of the invention also can be used in the diagnostics field, as well as for further investigating the role of AIk1 in the progression of disorders associated with pathogenic angiogenesis. The invention also provides nucleic acid sequences encoding the foregoing antibodies, vectors containing the same, pharmaceutical compositions and kits with instructions for use. | 05-12-2011 |
Corinne Petit-Frère, Munich DE
| Patent application number | Description | Published |
|---|---|---|
| 20110110944 | ANTI-ALK1 ANTIBODIES AND USES THEREOF - The present invention provides recombinant antigen-binding regions and antibodies and functional fragments containing such antigen-binding regions that are specific for AIk1, which plays an integral role in various disorders or conditions, such as cancer and macular degeneration. These antibodies, accordingly, can be used to treat these and other disorders and conditions. Antibodies of the invention also can be used in the diagnostics field, as well as for further investigating the role of AIk1 in the progression of disorders associated with pathogenic angiogenesis. The invention also provides nucleic acid sequences encoding the foregoing antibodies, vectors containing the same, pharmaceutical compositions and kits with instructions for use. | 05-12-2011 |
Corinne Ploix, Riedisheim FR
| Patent application number | Description | Published |
|---|---|---|
| 20110091913 | DRUG SAFETY TEST USING PENTRAXIN-3 (PTX-3) - The invention relates to an in vitro method for assessing the immunogenicity of a compound of interest comprising the steps of: a) providing a whole blood sample, wherein said blood was exposed to said compound of interest, b) measuring the level of pentraxin-3 in said sample, and c) comparing the measured level of pentraxin-3 with a control. | 04-21-2011 |
Corinne Poree, Rennes FR
| Patent application number | Description | Published |
|---|---|---|
| 20110148903 | Image display system comprising a viewing conditions sensing device - The viewing conditions sensing device comprises an image sensing device and is able to output target viewing conditions under which the image display device displays images. Then, a color appearance adaptation module transform reference colors of images delivered under reference viewing conditions into target colors under target viewing conditions, according to a color appearance model, as the CIECAM, differentiating a display field from a surround field. According to the invention, the viewing conditions sensing device further comprises identifying means adapted for identifying, within the sensing images, the contour of the display field. The background and the surround are therefore better connected and the CIECAM model can be implemented more efficiently. | 06-23-2011 |
Corinne Poulard, Orlienas FR
| Patent application number | Description | Published |
|---|---|---|
| 20120090892 | HIGH VOLTAGE ELECTRIC TRANSMISSION CABLE - An electric cable ( | 04-19-2012 |
Corinne Reich-Weiser, Menlo Park, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110178938 | SYSTEM AND METHOD FOR ASSESSING ENVIRONMENTAL FOOTPRINT - An environmental footprint assessment system is disclosed. The environmental footprint assessment system determines the environment footprint of an entity by analyzing financial information regarding the entity. For example, the environmental footprint assessment system may determine the carbon footprint of a business. The environmental footprint assessment system compares an entity's financial information against a database of environmental impacts to produce an initial carbon footprint assessment for the entity. The initial assessment is reviewed for areas of spending that contribute significant to the entity's carbon footprint. The database of environmental impacts can be refined with additional environmental impact information regarding the areas of significant carbon contribution. A subsequent iteration of the carbon footprint assessment is performed, and an updated carbon footprint assessment is produced. The process is repeatedly iteratively to produce additional carbon footprint assessments. | 07-21-2011 |
Corinne Reisert, Mannheim DE
| Patent application number | Description | Published |
|---|---|---|
| 20090248558 | Managing Consistent Interfaces for Business Objects Across Heterogeneous Systems - A business object model, which reflects data that is used during a given business transaction, is utilized to generate interfaces. This business object model facilitates commercial transactions by providing consistent interfaces that are suitable for use across industries, across businesses, and across different departments within a business during a business transaction. In some operations, software creates, updates, or otherwise processes information related to a funds management center, an individual material, and/or a measuring device business object. | 10-01-2009 |
| 20090326988 | MANAGING CONSISTENT INTERFACES FOR BUSINESS OBJECTS ACROSS HETEROGENEOUS SYSTEMS - A business object model, which reflects data that is used during a given business transaction, is utilized to generate interfaces. This business object model facilitates commercial transactions by providing consistent interfaces that are suitable for use across industries, across businesses, and across different departments within a business during a business transaction. In some operations, software creates, updates, or otherwise processes information related to a budget availability control register, a financial accounting view of work order, a funds commitment document, an insurance contract, and/or a project cost estimate business object. | 12-31-2009 |
| 20110276360 | MANAGING CONSISTENT INTERFACES FOR BUSINESS OBJECTS ACROSS HETEROGENEOUS SYSTEMS - A business object model, which reflects data that is used during a given business transaction, is utilized to generate interfaces. This business object model facilitates commercial transactions by providing consistent interfaces that are suitable for use across industries, across businesses, and across different departments within a business during a business transaction. In some operations, software creates, updates, or otherwise processes information related to a budget availability control register, a financial accounting view of work order, a funds commitment document, an insurance contract, and/or a project cost estimate business object. | 11-10-2011 |
Corinne Reymermier, Charly FR
| Patent application number | Description | Published |
|---|---|---|
| 20100040710 | Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers. - The invention relates to the stimulation of the synthesis and of the activity of an isoform of lysyl oxidase, and more particularly of the LOXL (lysyl oxidase-like) isoform. | 02-18-2010 |
| 20100047361 | Active Principle which is capable of inducing the conversion of inactive TGFb-Latent into active TGFb - The invention relates to active principles which are capable of inducing the conversion of inactive TGFb-Latent into active TGFb. The invention relates in particular to the use of such an extract for the manufacture of a composition for increasing the concentration of active TGFb1 in the skin, notably in the dermis. | 02-25-2010 |
| 20100143512 | NOVEL SEBUM SECRETION INHIBITORY AGENT - The present invention relates to a novel sebum secretion inhibitor and use thereof for the production of cosmetic and pharmaceutical, notably dermatological, compositions, intended for preventing and/or reducing the secretion of sebum and notably of squalene. | 06-10-2010 |
| 20100209407 | MC-1R, MC-2R, AND/OR MU OPIOID RECEPTORS MODULATION - The invention concerns active substances modulating the expression of the receptors of the products of the POMC gene (MC-IR, MC-2R, and the μ opioid receptor), and possibly modulating the expression of POMC in cutaneous cells, notably to modulate the proliferation and differentiation of epidermal cells in order to re-epithelial, maintain innervation, irrigate the skin, or restore normal pigmentation, or to fight against aging, or to modulate pigmentation independently or not of cutaneous aging. The invention also concerns a method of screening such active substances. | 08-19-2010 |
| 20100272699 | MC-1R, MC-2R, and/or OPIOID RECEPTORS STIMULATION - The invention concerns active substances modulating the expression of the receptors of the products of the POMC gene (MC-IR, MC-2R, and the μ opioid receptor), and possibly modulating the expression of POMC in cutaneous cells, notably to modulate the proliferation and differentiation of epidermal cells in order to re-epithelial, maintain innervation, irrigate the skin, or to fight against aging, or to modulate pigmentation independently or not of cutaneous aging. The invention also concerns a method of screening such active substances. | 10-28-2010 |
| 20110014175 | STIMULATION OF THE SYNTHESIS OF THE ACTIVITY OF AN ISOFORM OF LYSL OXIDASE-LIKE LOXL FOR STIMULATING THE FORMATION OF ELASTIC FIBRES - The invention relates to the stimulation of the synthesis and of the activity of an isoform of lysyl oxidase, and more particularly of the LOXL (lysyl oxidase-like) isoform. | 01-20-2011 |
| 20110223264 | Substancefor Restoring Normal Co-expression and Interaction Between the LOX and NRAGE Proteins - The invention relates to a substance for restoring normal co-expression and interaction between the LOX and NRAGE proteins. | 09-15-2011 |
| 20110244063 | NOVEL SEBUM SECRETION INHIBITORY AGENT - The present invention relates to a novel sebum secretion inhibitor and use thereof for the production of cosmetic and pharmaceutical, notably dermatological, compositions, intended for preventing and/or reducing the secretion of sebum and notably of squalene. | 10-06-2011 |
Corinne Schall, Strasbourg FR
| Patent application number | Description | Published |
|---|---|---|
| 20080210127 | PREFABRICATED MEMBRANE BASED ON MODIFIED POLYURETHANE BITUMINOUS BINDER AND PROCESS FOR PRODUCTION - The present invention has for its object a prefabricated sealing membrane formed by a support, coated on at least one surface, and preferably impregnated throughout, with a modified bitumen base composition, characterized in that the thermoplastic bituminous composition for coating and/or impregnation is a bituminous binder modified by a thermoplastic polyurethane having the following weight proportion: | 09-04-2008 |
Corinne Soulie-Ziakovic, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20080221272 | Polymer Material Comprising Chains Bearing Imidazolidone Functions - The invention concerns a polymer material consisting of macromolecular chains bound by hydrogen bonds wherein: the macromolecular chains consist of a polymer skeleton whereon is fixed by at least one covalent bond a modifying agent, the modifying agent comprising, assembled in a common molecule, one or more associative groups capable of being bound by hydrogen bonds and one or more reactive groups capable of forming covalent bonds with the polymer skeleton, at least one of the associative groups of the modifying agent is an imidazolidone heterocycle, the macromolecular chains bear on average 1 to 10 imidazolidone groups per chain. The average number of imidazolidone groups to be introduced into the macromolecular chains depends both on the average mass of said chains and the final properties desired for the material. The inventive polymer material can be extruded, co-extruded, injected, blown, moulded, overmoulded, calandered, thermoformed. It can be used to produce articles such as tubes, films, plates, extruded strings, bottles, containers. The inventive polymer material can also be mixed with other materials such as other polymers, thus it is used for example as impact modifier or rheology regulator. The invention further concerns the use of said polymer material as compatibility agent in a composition comprising among others at least two polymers belonging to different classes of polymers. | 09-11-2008 |
| 20090062551 | ELASTIC MATERIALS - The present invention relates to materials exhibiting the property of rubbery elasticity, consisting of molecules with a mass of between 9 and 9000 g/mol, all or some of the molecules having at least three groups (also referred to as “associative groups”) capable of associating via non-covalent interactions. | 03-05-2009 |
| 20110135859 | POLYMER MATERIAL CONTAINING CHAINS BEARING IMIDAZOLIDONE FUNCTIONS - The invention concerns a polymer material consisting of macromolecular chains bound by hydrogen bonds, wherein: the macromolecular chains consist of a polymer skeleton whereon is fixed by at least one covalent bond a modifying agent, the modifying agent comprising, assembled in a common molecule, one or more associative groups capable of being bound by hydrogen bonds and one or more reactive groups capable of forming covalent bonds with the polymer skeleton, at least one of the associative groups of the modifying agent is an imidazolidone heterocycle, the macromolecular chains bear on average, 1 to 10 imidazolidone groups per chain. The average number of imidazolidone groups to be introduced into the macromolecular chains depends both on the average mass of said chains and the final properties desired for the material. | 06-09-2011 |
Corinne Venot, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20090082329 | Novel Sulphur-Containing Cyclic Urea Derivatives, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors - The disclosure relates to compounds of formula (I): | 03-26-2009 |
| 20090082379 | Novel Cyclic Urea Derivatives, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors - Compounds of formula (I): | 03-26-2009 |
Corinne Zuppiger-Lachat, Bienne CH
| Patent application number | Description | Published |
|---|---|---|
| 20090042416 | METHOD FOR THE SOLDERLESS CONNECTION OF AN ELECTRIC ACTUATOR TO A PRINTED CIRCUIT, WHICH IS PARTICULARLY SUITABLE FOR MOTOR VEHICLE DASHBOARDS - A method of connecting an electric actuator to a printed circuit by metal contacts having an open contact zone. The metal contacts are soldered to the printed circuit using an SMD-type automated method performed at a high speed and at a high temperature, and the electrical connection pins of the actuator can be mechanically connected to the metal contacts without soldering by butting the contact zone of the metal contacts against the connection pins of the actuator once the connection pins have been inserted through the contact zone. | 02-12-2009 |
Corinne Zuppigger-Lachat, Bienne CH
| Patent application number | Description | Published |
|---|---|---|
| 20090173271 | DASHBOARD INDICATOR MODULE - A dashboard indicator module including a rotating actuator including a hollow output shaft controlling movement of an indicator with a light conducting path, connected to a light source, diffusing a light at an angle, and a reduction gear set. The external diameter of the conducting path is between 2.6 and 5.5 millimeters. | 07-09-2009 |